Characterization of a diffuse intrinsic pontine glioma cell line: Implications for future investigations and treatment

Journal of Neuro-Oncology

Volumn 110, Issue 3, 2012, Pages 305-313

  Hashizume, Rintaro ^a   Smirnov, Ivan ^a   Liu, Sharon ^a   Phillips, Joanna J ^a   Hyer, Jeanette ^a   McKnight, Tracy R ^a   Wendland, Michael ^a   Prados, Michael ^a   Banerjee, Anu ^a   Nicolaides, Theodore ^a   Mueller, Sabine ^a   James, Charles D ^a   Gupta, Nalin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Animal model; Astrocytoma; Brainstem glioma

Indexed keywords

CAPECITABINE; LUCIFERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATAXIA; BIOLUMINESCENCE; BRAIN STEM TUMOR; CASE REPORT; CHILD; DIPLOPIA; DISEASE COURSE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEREDITY; HISTOPATHOLOGY; HUMAN; IN VITRO PROPAGATION; IN VIVO STUDY; MALE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PONTINE GLIOMA; PRESCHOOL CHILD; RAT; STEREOTACTIC PROCEDURE; SURGICAL TECHNIQUE; TUMOR LOCALIZATION;

ANIMALS; BLOTTING, WESTERN; BRAIN STEM NEOPLASMS; CHILD; FEMALE; GENE EXPRESSION PROFILING; GLIOMA; HUMANS; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PONS; RATS; RATS, NUDE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 84871307772     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-012-0973-6     Document Type: Article

References (22)

1. Donaldson SS, Laningham F, Fisher PG (2006) Advances toward an understanding of brainstem gliomas. J Clin Oncol 24(8):1266-1272. doi:10.1200/JCO.2005.04.6599
2. Recinos PF, Sciubba DM, Jallo GI (2007) Brainstem tumors: where are we today? Pediatr Neurosurg 43(3):192-201. doi:10.1159/000098831
3. Finlay JL, Zacharoulis S (2005) The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical - and futuristic-perspective. J Neurooncol 75(3):253-266. doi:10.1007/s11060-005- 6747-7
4. Sharp JR, Bouffet E, Stempak D, Gammon J, Stephens D, Johnston DL, Eisenstat D, Hukin J, Samson Y, Bartels U, Tabori U, Huang A, Baruchel S (2010) A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma. Eur J Cancer 46(18):3271-3279. doi:10.1016/j.ejca.2010.06.115
5. Huse JT, Phillips HS, Brennan CW (2011) Molecular subclassification of diffuse gliomas: seeing order in the chaos. Glia 59(8):1190-1199. doi:10.1002/glia.21165
6. Phillips HS, Kharbanda S, Chen R, Forrest WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, Williams PM, Modrusan Z, Feuerstein BG, Aldape K (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 9(3):157-173. doi:10.1016/j.ccr.2006.02.019
7. Paugh BS, Broniscer A, Qu C, Miller CP, Zhang J, Tatevossian RG, Olson JM, Geyer JR, Chi SN, da Silva NS, Onar-Thomas A, Baker JN, Gajjar A, Ellison DW, Baker SJ (2011) Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. J Clin Oncol 29(30):3999-4006. doi:10.1200/JCO.2011.35.5677
8. Wu G, Broniscer A, McEachron TA, Lu C, Paugh BS, Becksfort J, Qu C, Ding L, Huether R, Parker M, Zhang J, Gajjar A, Dyer MA, Mullighan CG, Gilbertson RJ, Mardis ER, Wilson RK, Downing JR, Ellison DW, Baker SJ (2012) Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and nonbrainstem glioblastomas. Nat Genet. doi:10.1038/ng.1102
9. Aoki Y, Hashizume R, Ozawa T, Banerjee A, Prados M, James CD, Gupta N (2012) An experimental xenograft mouse model of diffuse pontine glioma designed for therapeutic testing. J Neurooncol. doi:10.1007/s11060-011-0796-x
10. Hashizume R, Ozawa T, Dinca EB, Banerjee A, Prados MD, James CD, Gupta N (2010) A human brainstem glioma xenograft model enabled for bioluminescence imaging. J Neurooncol 96(2):151-159. doi:10.1007/s11060-009-9954-9
11. Caretti V, Zondervan I, Meijer DH, Idema S, Vos W, Hamans B, Bugiani M, Hulleman E, Wesseling P, Vandertop WP, Noske DP, Kaspers G, Molthoff CF, Wurdinger T (2010) Monitoring of tumor growth and post-irradiation recurrence in a diffuse intrinsic pontine glioma mouse model. Brain Pathol. doi:10.1111/j.1750-3639.2010.00468.x
12. Monje M, Mitra SS, Freret ME, Raveh TB, Kim J, Masek M, Attema JL, Li G, Haddix T, Edwards MS, Fisher PG, Weissman IL, Rowitch DH, Vogel H, Wong AJ, Beachy PA (2011) Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc Natl Acad Sci U S A 108(11):4453-4458. doi:10.1073/pnas.1101657108
13. Sanai N, Wachhorst SP, Gupta NM, McDermott MW (2008) Transcerebellar stereotactic biopsy for lesions of the brainstem and peduncles under local anesthesia. Neurosurgery 63(3):460-466; discussion 466-468. doi:10.1227/01.NEU. 0000324731.68843.74
14. Gunther HS, Schmidt NO, Phillips HS, Kemming D, Kharbanda S, Soriano R, Modrusan Z, Meissner H, Westphal M, Lamszus K (2008) Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria. Oncogene 27(20):2897-2909. doi:10.1038/sj.onc.1210949
15. Dinca EB, Sarkaria JN, Schroeder MA, Carlson BL, Voicu R, Gupta N, Berger MS, James CD (2007) Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy. J Neurosurg 107(3):610-616. doi:10.3171/JNS-07/09/0610
16. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, Hakonarson H, Bucan M (2007) PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 17(11):1665-1674. doi:10.1101/gr.6861907
17. Paugh BS, Qu C, Jones C, Liu Z, Adamowicz-Brice M, Zhang J, Bax DA, Coyle B, Barrow J, Hargrave D, Lowe J, Gajjar A, Zhao W, Broniscer A, Ellison DW, Grundy RG, Baker SJ (2010) Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. J Clin Oncol 28(18):3061-3068. doi:10.1200/JCO.2009.26.7252
18. Johnson RA, Wright KD, Poppleton H, Mohankumar KM, Finkelstein D, Pounds SB, Rand V, Leary SE, White E, Eden C, Hogg T, Northcott P, Mack S, Neale G, Wang YD, Coyle B, Atkinson J, DeWire M, Kranenburg TA, Gillespie Y, Allen JC, Merchant T, Boop FA, Sanford RA, Gajjar A, Ellison DW, Taylor MD, Grundy RG, Gilbertson RJ (2010) Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 466(7306):632-636. doi:10.1038/ nature09173
19. Zarghooni M, Bartels U, Lee E, Buczkowicz P, Morrison A, Huang A, Bouffet E, Hawkins C (2010) Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights plateletderived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets. J Clin Oncol 28(8):1337-1344. doi:10.1200/JCO.2009.25.5463
20. Becher OJ, Hambardzumyan D, Walker TR, Helmy K, Nazarian J, Albrecht S, Hiner RL, Gall S, Huse JT, Jabado N, MacDonald TJ, Holland EC (2010) Preclinical evaluation of radiation and perifosine in a genetically and histologically accurate model of brainstem glioma. Cancer Res 70(6):2548-2557. doi:10.1158/0008-5472.CAN-09-2503
21. Masui K, Suzuki SO, Torisu R, Goldman JE, Canoll P, Iwaki T (2010) Glial progenitors in the brainstem give rise to malignant gliomas by platelet-derived growth factor stimulation. Glia 58(9):1050-1065. doi:10.1002/glia.20986
22. Wen VW, Wu K, Baksh S, Hinshelwood RA, Lock RB, Clark SJ, Moore MA, Mackenzie KL (2006) Telomere-driven karyotypic complexity concurs with p16INK4a inactivation in TP53-competent immortal endothelial cells. Cancer Res 66(22):10691-10700. doi:10.1158/0008-5472.CAN-06-0979